Trial record 11 of 104 for:
ovarian cancer olaparib
Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04377087 |
|
Recruitment Status :
Recruiting
First Posted : May 6, 2020
Last Update Posted : August 7, 2020
|
Sponsor:
Sarah E Taylor
Collaborator:
American Society of Clinical Oncology
Information provided by (Responsible Party):
Sarah E Taylor, University of Pittsburgh
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2023 |
| Estimated Study Completion Date : | May 2024 |